Your selection

Innovation / 14.11.2023
Eckert & Ziegler Establishess German-Chinese Joint Venture with DC Pharma for the Production of Radioisotopes

Insider information pursuant to Article 17 MAR

Eckert & Ziegler (ISIN DE0005659700) strengthens its competitive position in the growth market of China and today signed a 50:50 joint venture agreement with the Chinese pharmaceutical company DongCheng Pharma (DC Pharma).

Eckert & Ziegler will benefit from the cooperation between the two companies above all at its production site in Jintan near Shanghai. Here, the radioisotopes urgently needed for cancer diagnostics and therapy on the growing Chinese market shall be produced and commercialized.

DC Pharma invests € 20 million in the EZAG subsidiary Qi Kang Medical Technology (Changzhou) Co., Ltd. by way of a capital increase and will subsequently hold 50% of the shares.

The joint venture will complete the production facility currently under construction in Jintan and start the production of cyclotron-based isotopes in a first phase. In a second phase, further production lines for radioisotopes such as Lu-177 are to follow.

DC Pharma is one of the leading radiopharmaceutical companies in China with sales of 498 million US$ or 3.6 billion CNY (2022). With its market position, experience in production and sales, it is the ideal partner for Eckert & Ziegler.

Overview News

News Buch Berlin

FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications

FyoniBio, a contract development organization (CDO) specializing in customized cell line and process development has partnered with BioLamina, a biotech company renowned for its expertise in extracell...

more ...

Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals

Eckert & Ziegler (ISIN DE0005659700, SDAX) and Full-Life Technologies (Full-Life), a clinical stage, fully integrated global radiotherapeutics company today announced they have entered into an agreeme...

more ...

Third ERC Grant for Gaetano Gargiulo

Cell-based immunotherapies, particularly lab-produced immune cells known as CAR T cells, show promise in treating various cancers. But how do we produce effective ones? Gaetano Gargiulo from the Max D...

more ...

Events Buch Berlin

02.03.2024, 10:00
Floorball Girls´Day Berlin 2024

Technik-Training, Parcour, Short-Games, Gewinnspiel ab 14:00 Uhr: Floorball-Damenbundesliga BB United – Dragons Bonn.

more ...

02.03.2024, 16:30
Benefizkonzert zugunsten Ukrainehilfe

des Vereins Kunstbrücke Panketal e.V.

more ...

05.03.2024, 15:00
Freundschaft oder Liebe? Lesung mit Natalja Sharandak

Die Geschichte der Beziehungen zweier Ikonen der ukrainischen Moderne Lesja Ukrajinka und Olga Kobyljanska

more ...

This website is supported by: